
TransCode Therapeutics, Inc. - Common Stock
Share · US89357L3033 · RNAZ (XNAS)
7,50 USD
10.06.2025 19:59
Current Prices from TransCode Therapeutics, Inc. - Common Stock
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
RNAZ
|
USD
|
10.06.2025 19:59
|
7,50 USD
| 7,45 USD
+0,67 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 0,27 % | -19,63 % | -80,85 % | -96,83 % | -99,37 % | -100,00 % |
Company Profile for TransCode Therapeutics, Inc. - Common Stock Share
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inhibitor of RNA-binding protein LIN28B. Its cancer agnostic programs comprise TTX-RIGA, an RNAbased agonist of the RIG-I-driven immune response in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines meant to activate cytotoxic immune responses against tumor cells. The company was incorporated in 2016 and is based in Boston, Massachusetts.
Company Data
Name TransCode Therapeutics, Inc. - Common Stock
Company TransCode Therapeutics, Inc.
Symbol RNAZ
Primary Exchange
NASDAQ

ISIN US89357L3033
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Thomas A. Fitzgerald M.B.A.
Country United States of America
Currency USD
Employees 0,0 T
Address 6 Liberty Square, 02109 Boston
IPO Date 2021-07-08
Stock Splits
Date | Split |
---|---|
15.05.2025 | 1:28 |
04.12.2024 | 1:33 |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | RNAZ |
More Shares
Investors who TransCode Therapeutics, Inc. - Common Stock hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.